Krish Krishnan, Krystal Biotech CEO
Krystal Biotech raises $160M via PIPE on heels of FDA approval for gene therapy
Krystal Biotech has received $160 million in private financing days after the FDA approved Vyjuvek, a gene therapy for children with a rare skin …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
